Jazz Pharmaceuticals plc - SHS USD (JAZZ)

CUSIP: G50871105

Q1 2018 13F Holders as of 31 Mar 2018

Type / Class
Equity / SHS USD
Total 13F shares
53,679,721
Share change
-550,605
Total reported value
$8,093,065,376
Put/Call ratio
111%
Price per share
$150.99
Number of holders
320
Value change
-$76,065,361
Number of buys
152
Number of sells
150

Quarterly Holders Quick Answers

What is CUSIP G50871105?
CUSIP G50871105 identifies JAZZ - Jazz Pharmaceuticals plc - SHS USD in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q1 2018

As of 31 Mar 2018, Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by 320 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 53,679,721 shares. The largest 10 holders included PUTNAM INVESTMENTS LLC, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, Bank of New York Mellon Corp, Senator Investment Group LP, TIAA CREF INVESTMENT MANAGEMENT LLC, CADIAN CAPITAL MANAGEMENT, LP, and WESTFIELD CAPITAL MANAGEMENT CO LP. This page lists 320 institutional shareholders reporting positions in this security for the Q1 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.